Rock Springs Capital Management LP
Filing Date
Global Rank
#1,317
/ 8,700
▲ 314
Top Industry
Biotechnology
73.3%
Period ended 2 months ago
Filed Aug 14, 2026 · 29d
26 quarters · since Mar 2020
Portfolio Concentration
104 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
10.1%
+2.9 pts
Top 5
31.1%
+4.0 pts
Top 10
44.0%
+2.0 pts
HHI
305
Diversified+34
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,048,809,888 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | +701,115 | 2,179,069 | $123,792,909 | |
| MMED | MiniMed Group, Inc. | +465,000 | 1,520,000 | $22,724,000 | |
| ERAS | Erasca, Inc. | +298,681 | 1,402,150 | $25,687,388 | |
| CMPX | Compass Therapeutics, Inc. | +219,621 | 3,524,929 | $7,719,594 | |
| CYTK | Cytokinetics Inc | +142,616 | 187,980 | $16,014,016 | |
| INSP | Inspire Medical Systems, Inc. | +112,200 | 244,000 | $10,884,840 | |
| PHR | Phreesia, Inc. | +96,500 | 696,900 | $7,171,101 | |
| TNGX | Tango Therapeutics, Inc. | +69,636 | 456,551 | $14,271,784 | |
| OLMA | Olema Pharmaceuticals, Inc. | +64,800 | 235,178 | $2,942,076 | |
| TARS | Tarsus Pharmaceuticals, Inc. | +51,908 | 277,087 | $17,439,855 | |
| CLDX | Celldex Therapeutics, Inc. | +48,876 | 699,146 | $26,015,222 | |
| INSM | INSMED Inc | +47,850 | 362,150 | $38,612,433 | |
| BCAX | Bicara Therapeutics Inc. | +46,191 | 535,286 | $15,892,641 | |
| INDV | Indivior Pharmaceuticals, Inc. | +45,500 | 245,500 | $10,072,865 | |
| MLYS | Mineralys Therapeutics, Inc. | +45,200 | 484,951 | $13,083,977 | |
| CORT | Corcept Therapeutics Inc | +21,750 | 72,000 | $6,260,400 | |
| BBIO | BridgeBio Pharma, Inc. | +16,500 | 144,750 | $10,780,980 | |
| ALKS | Alkermes plc. | +15,825 | 199,811 | $10,470,096 | |
| DHR | Danaher Corp /De/ | +14,800 | 76,300 | $14,533,624 | |
| SYK | Stryker Corp | +14,200 | 29,000 | $9,130,360 | |
| TEVA | Teva Pharmaceutical Industries Ltd | +13,500 | 59,000 | $1,998,920 | |
| BSX | Boston Scientific Corp | +13,200 | 528,500 | $22,556,380 | |
| UNH | Unitedhealth Group Inc | +10,750 | 63,750 | $26,496,412 | |
| MBX | MBX Biosciences, Inc. | +10,251 | 298,218 | $16,461,633 | |
| ATEC | Alphatec Holdings, Inc. | +10,000 | 360,000 | $3,114,000 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | −361,875 | 464,625 | $23,579,718 | |
| AGIO | Agios Pharmaceuticals, Inc. | −266,600 | 532,563 | $19,763,412 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −250,918 | 967,855 | $32,316,678 | |
| EVH | Evolent Health, Inc. | −175,000 | 2,500,000 | $13,550,000 | |
| OMDA | Omada Health, Inc. | −168,000 | 373,000 | $8,187,350 | |
| AZTA | Azenta, Inc. | −166,100 | 403,000 | $10,284,560 | |
| ACRS | Aclaris Therapeutics, Inc. | −142,118 | 4,330,532 | $22,908,514 | |
| SGRY | Surgery Partners, Inc. | −124,000 | 84,000 | $1,411,200 | |
| COGT | Cogent Biosciences, Inc. | −108,238 | 515,917 | $19,965,987 | |
| RVMD | Revolution Medicines, Inc. | −104,255 | 1,105,210 | $206,983,728 | |
| XENE | Xenon Pharmaceuticals Inc. | −79,113 | 683,907 | $41,280,626 | |
| VERA | Vera Therapeutics, Inc. | −76,001 | 427,584 | $18,347,629 | |
| CAI | Caris Life Sciences, Inc. | −75,500 | 487,500 | $8,687,250 | |
| VKTX | Viking Therapeutics, Inc. | −70,500 | 25,500 | $994,755 | |
| ARDX | Ardelyx, Inc. | −57,704 | 2,241,769 | $11,433,021 | |
| MLTX | MoonLake Immunotherapeutics | −51,004 | 10,696 | $208,251 | |
| ARGX | Argenx SE | −45,750 | 52,750 | $48,939,867 | |
| KYMR | Kymera Therapeutics, Inc. | −43,715 | 453,156 | $51,963,398 | |
| DYN | Dyne Therapeutics, Inc. | −30,044 | 942,154 | $20,925,240 | |
| NVO | Novo Nordisk A S | −26,500 | 63,500 | $3,044,190 | |
| ASND | Ascendis Pharma A/S | −25,250 | 168,750 | $45,009,000 | |
| SRRK | Scholar Rock Holding Corp | −24,364 | 715,452 | $39,349,860 | |
| MIRM | Mirum Pharmaceuticals, Inc. | −13,149 | 798,145 | $93,438,835 | |
| DXCM | Dexcom Inc | −12,600 | 343,000 | $23,101,050 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | −7,250 | 66,750 | $20,093,752 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
16 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AVLN | Avalyn Pharma Inc. | 662,918 | $21,823,260 | |
| COAG | Hemab Therapeutics Holdings, Inc. | 575,432 | $21,135,617 | |
| PBLS | Parabilis Medicines, Inc. | 578,028 | $15,820,626 | |
| OMER | Omeros Corp | 718,499 | $6,832,925 | |
| DFTX | Definium Therapeutics, Inc. | 143,187 | $6,735,516 | |
| MOBI | Mobia Medical, Inc. | 418,200 | $5,603,880 | |
| TRVI | Trevi Therapeutics, Inc. | 260,000 | $4,849,000 | |
| SYRE | Spyre Therapeutics, Inc. | 42,254 | $3,751,310 | |
| NGEN | Nervgen Pharma Corp. | 1,208,231 | $2,488,955 | |
| MDT | Medtronic plc | 30,900 | $2,417,307 | |
| SGMT | Sagimet Biosciences Inc. | 250,000 | $1,932,500 | |
| CAPR | Capricor Therapeutics, Inc. | 74,448 | $1,792,707 | |
| ALT | Altimmune, Inc. | 471,465 | $1,433,253 | |
| KLRA | Kailera Therapeutics, Inc. | 65,000 | $1,431,950 | |
| AXSM | Axsome Therapeutics, Inc. | 5,500 | $1,346,235 | |
| GKOS | GLAUKOS Corp | 4,750 | $663,860 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
12 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | 10,100 | $7,803,664 | |
| BWX | State Street SPDR Bloomberg International Treasury Bond ETF | 30,000 | $3,831,900 | |
| EW | Edwards Lifesciences Corp | 28,900 | $2,314,312 | |
| ACHC | Acadia Healthcare Company, Inc. | 75,500 | $1,765,945 | |
| JAZZ | Jazz Pharmaceuticals plc | 5,750 | $1,087,037 | |
| GOSS | Gossamer Bio, Inc. | 1,609,492 | $529,522 | |
| — | 162,750 | $0 | ||
| — | 169,859 | $0 | ||
| — | 257,253 | $0 | ||
| — | 113,748 | $0 | ||
| — | 21,062 | $0 | ||
| CNTA | Centessa Pharmaceuticals plc | 351,828 | $0 | |
| No positions match the current search. | ||||
104 tracked positions ·
$2,048,809,888 total
· filing declares
104 positions · $2,048,808,191
· as of Jun 30, 2026
Showing 1–50
of 104 positions by value
· page 1 of 3
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 1,105,210 | $206,983,728 | 10.10% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Added | 2,179,069 | $123,792,909 | 6.04% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Held | 98,700 | $118,383,750 | 5.78% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 174,999 | $93,965,713 | 4.59% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 798,145 | $93,438,835 | 4.56% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 692,598 | $76,899,155 | 3.75% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Reduced | 453,156 | $51,963,398 | 2.54% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 52,750 | $48,939,867 | 2.39% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 168,750 | $45,009,000 | 2.20% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 683,907 | $41,280,626 | 2.01% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Reduced | 715,452 | $39,349,860 | 1.92% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 362,150 | $38,612,433 | 1.88% | |
| PEN |
Penumbra Inc
Healthcare
|
Reduced | 115,750 | $36,548,062 | 1.78% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 640,317 | $34,365,813 | 1.68% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Reduced | 967,855 | $32,316,678 | 1.58% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 269,650 | $32,074,867 | 1.57% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 76,460 | $30,406,612 | 1.48% | |
| AGL |
agilon health, inc.
Healthcare
|
Added | 262,600 | $28,145,468 | 1.37% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 63,750 | $26,496,412 | 1.29% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 699,146 | $26,015,222 | 1.27% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 1,402,150 | $25,687,388 | 1.25% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 144,750 | $24,396,165 | 1.19% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Reduced | 464,625 | $23,579,718 | 1.15% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Held | 125,000 | $23,385,000 | 1.14% | |
| DXCM |
Dexcom Inc
Healthcare
|
Reduced | 343,000 | $23,101,050 | 1.13% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Reduced | 4,330,532 | $22,908,514 | 1.12% | |
| MMED |
MiniMed Group, Inc.
Healthcare
|
Added | 1,520,000 | $22,724,000 | 1.11% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 528,500 | $22,556,380 | 1.10% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 648,333 | $22,419,355 | 1.09% | |
| AVLN |
Avalyn Pharma Inc.
Healthcare
|
NEW | 662,918 | $21,823,260 | 1.07% | |
| COAG |
Hemab Therapeutics Holdings, Inc.
Healthcare
|
NEW | 575,432 | $21,135,617 | 1.03% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 942,154 | $20,925,240 | 1.02% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Reduced | 66,750 | $20,093,752 | 0.98% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 515,917 | $19,965,987 | 0.97% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Reduced | 532,563 | $19,763,412 | 0.96% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Reduced | 582,744 | $19,749,194 | 0.96% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 427,584 | $18,347,629 | 0.90% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 277,087 | $17,439,855 | 0.85% | |
| HTFL |
Heartflow, Inc.
Healthcare
|
Added | 573,500 | $16,826,490 | 0.82% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 298,218 | $16,461,633 | 0.80% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 187,980 | $16,014,016 | 0.78% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 535,286 | $15,892,641 | 0.78% | |
| PBLS |
Parabilis Medicines, Inc.
Healthcare
|
NEW | 578,028 | $15,820,626 | 0.77% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Held | 814,707 | $15,479,433 | 0.76% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Added | 76,300 | $14,533,624 | 0.71% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Added | 456,551 | $14,271,784 | 0.70% | |
| EVH |
Evolent Health, Inc.
Healthcare
|
Reduced | 2,500,000 | $13,550,000 | 0.66% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 162,298 | $13,238,647 | 0.65% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 484,951 | $13,083,977 | 0.64% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Held | 502,077 | $12,742,714 | 0.62% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.